Carisma Therapeutics
www.carismatx.comCarisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
Read more
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
Read more
Country
State
Pennsylvania
City (Headquarters)
Philadelphia
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Clinical Research
Email ****** @****.comPhone (***) ****-****Chief Technology and Development Officer; Vice President , Development
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Principal Scientist , Head of Protein Engineering
Email ****** @****.comPhone (***) ****-****
Technologies
(21)
Reach decision makers at Carisma Therapeutics
Free credits every month!
Carisma Therapeutics FAQ
Philadelphia, United States
Biotechnology Research
